Salicylic acid

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the treatment of skin tags.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

There is currently no specific dosage and administration information available for this medication. Healthcare professionals are advised to refer to the prescribing information or clinical guidelines for detailed instructions regarding the appropriate dosage, route of administration, and frequency of use. It is essential to consider individual patient factors and clinical judgment when determining the appropriate treatment regimen.

Contraindications

Use of this product is contraindicated in individuals with a known allergy to any of its ingredients. Additionally, the product should not be used if it is damaged or broken, as this may compromise its safety and efficacy.

Warnings and Precautions

The product is intended for adult external use only and is classified as flammable. It is imperative to keep the product away from heat sources and open flames to prevent fire hazards. The use of this product is contraindicated in pregnant women and children, as well as on open skin wounds, to avoid potential adverse effects.

General precautions should be observed to ensure safe application. Contact with the eyes must be strictly avoided; in the event of exposure, the affected eye should be flushed with water for a minimum of 15 minutes. Inhalation of vapors should also be avoided to prevent respiratory irritation. The bottle should be capped tightly after use to maintain product integrity. Additionally, the product should be stored out of direct sunlight and at room temperature, away from heat sources, to preserve its efficacy.

No specific laboratory tests are recommended for monitoring the use of this product. However, healthcare professionals should remain vigilant for any adverse reactions and provide appropriate guidance to patients regarding the safe use of the product.

Side Effects

Patients should be aware of several important warnings associated with the use of this product. It is intended for adult external use only and is flammable; therefore, it should be kept away from heat or flame.

The product is contraindicated in certain populations, including pregnant women and children. Additionally, it should not be applied to open skin wounds. These precautions are critical to ensure the safety and well-being of patients using this product.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Skin Tag Pen. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not use this medication, as it is contraindicated in children. Additionally, it is important to keep this medication out of reach of children to prevent accidental ingestion or misuse. There are no specific dosage recommendations or study outcomes available for pediatric populations, emphasizing the need for caution in this demographic.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients should not use this medication. The potential risks associated with its use during pregnancy have not been established, and there is insufficient data to determine its safety for fetal outcomes. Healthcare professionals are advised to consider alternative treatments for pregnant women to avoid any potential harm to the developing fetus.

Lactation

Lactating mothers should not use this medication. There is no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is advised, and alternative treatments should be considered for nursing mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

The use of this product is contraindicated in pregnant women due to potential teratogenic effects. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no specified findings related to nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to avoid contact with the eyes when using this product. In the event that the product does come into contact with the eyes, patients should be instructed to flush the eyes with water for at least 15 minutes.

Patients should also be cautioned against inhaling vapors from the product to prevent respiratory irritation. It is important to emphasize the necessity of capping the bottle tightly after each use to maintain the product's integrity and prevent leakage.

Additionally, healthcare providers should inform patients about the proper storage conditions for the product. Patients should be instructed to store the product out of direct sunlight and at room temperature, ensuring it is kept away from heat sources to preserve its effectiveness.

Storage and Handling

The product is supplied in a container that must be capped tightly to maintain integrity. It should be stored at a temperature range of 15-30°C (59-86°F) to ensure optimal stability. Care should be taken to avoid freezing and to prevent exposure to excessive heat, which should not exceed 40°C (104°F).

Additionally, the product should be kept out of direct sunlight and away from heat or flame to preserve its quality and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Skin Tag Pen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)